Jan-Michael Peters | |
---|---|
Born | Schleswig-Holstein, Germany | 16 August 1962
Citizenship | German |
Alma mater |
|
Awards |
|
Scientific career | |
Fields | cell biology, molecular biology |
Institutions | |
Thesis | (1991) |
Doctoral advisor | Werner Franke |
Jan-Michael Peters (born 16 August 1962 in Schleswig-Holstein, Germany) is a cell- and molecular biologist. Since 2013, he is Scientific Director of the Research Institute of Molecular Pathology (IMP) in Vienna.
Jan-Michael Peters grew up in Schleswig-Holstein and referred to an interest in biology that goes back to his childhood. [1]
Peters started studying at the University of Kiel in 1982, where he received his pre-diploma in Biology. In 1988, he completed his diploma studies at the University of Heidelberg, where he also obtained his PhD in cell biology in 1991. Working with Werner Franke during his PhD studies, Peters discovered p97-ATPase and first characterized the 26S proteasome. [2]
Between 1992 and 1993, Peters continued working with Werner W. Franke as a postdoctoral fellow at the German Cancer Research Center DKFZ in Heidelberg, where he worked on the first purification and electron microscopy of 26S proteasome. [2]
In 1994, Peters joined the lab of Marc W. Kirschner at Harvard Medical School in Boston as a postdoctoral fellow. There, he discovered the anaphase promoting complex/cyclosome (APC/C) and other enzymes required for chromosome segregation.
In 1996, Peters moved to Vienna to become Junior Group Leader at the Research Institute of Molecular Pathology (IMP), and was promoted to Senior Scientist in 2002. In 2011, he became the institute's Scientific Deputy Director and in 2013 Scientific Director, succeeding Barry Dickson.
Peters’ research group studies the molecular mechanisms of chromosome organization, chromosome segregation and cell division in a variety of model organisms.
Peters characterized the regulation and operating principle of a number of proteins that are responsible for the correct chromosome segregation during mitosis. Using the enzyme Polo-like Kinase 1 (Pik1), Peters characterized a cell division enzyme that has shown to be a promising target for chemotherapy against certain cancers. [3] [4] [5]
Peters was the coordinator of the European Science Foundation network grant EuroDYNA (2005-2008) that is fostering interaction among various collaborative research projects. He contributed to this program when he discovered the relationship between two proteins, cohesin and CTCF, [6] in regulating the expression and transcription of genes. [7] [8]
Between 2004 and 2009, Peters also coordinated the EU funded research project MitoCheck, aimed at the identification of genes that play a key role in the process of mitosis. Between 2010 and 2015, he headed the follow-up project MitoSys, through which biologists, mathematicians, biochemists and biophysicists collaborated to reveal how genes and proteins orchestrate mitosis in human cells. This project was accompanied by an art project seeking to link science and society. [9] [10] [11] [12]
In cell biology, mitosis is a part of the cell cycle in which replicated chromosomes are separated into two new nuclei. Cell division by mitosis gives rise to genetically identical cells in which the total number of chromosomes is maintained. Therefore, mitosis is also known as equational division. In general, mitosis is preceded by S phase of interphase and is often followed by telophase and cytokinesis; which divides the cytoplasm, organelles and cell membrane of one cell into two new cells containing roughly equal shares of these cellular components. The different stages of mitosis altogether define the mitotic (M) phase of an animal cell cycle—the division of the mother cell into two daughter cells genetically identical to each other.
Kim Ashley Nasmyth is an English geneticist, the Whitley Professor of Biochemistry at the University of Oxford, a Fellow of Trinity College, Oxford, former scientific director of the Research Institute of Molecular Pathology (IMP), and former head of the Department of Biochemistry, University of Oxford. He is best known for his work on the segregation of chromosomes during cell division.
The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.
Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.
Frank Uhlmann FRS is a group leader at the Francis Crick Institute in London.
William Charles Earnshaw is Professor of Chromosome Dynamics at the University of Edinburgh where he has been a Wellcome Trust Principal Research Fellow since 1996.
Max Luciano Birnstiel was a Swiss molecular biologist who held a number of positions in scientific leadership in Europe, including the chair of the Institute of Molecular Biology at the University of Zurich from 1972–86, and that of founding director of the Research Institute of Molecular Pathology (IMP) in Vienna from 1986 to 1996. His research focused on gene regulation in eukaryotes. His research group is sometimes cited as the first to purify single genes, the ribosomal RNA genes from Xenopus laevis, three years before the successful isolation of the lac operon. He is also recognized for one of the earliest discoveries of a gene enhancer element. Birnstiel died in 2014 of heart failure during cancer treatment.
Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.
The Vienna BioCenter is a cluster of life science research institutes and biotechnology companies located in the 3rd municipal District of Vienna, Austria. It grew around the Research Institute of Molecular Pathology (IMP), which opened in 1988. The entities at the Vienna BioCenter employ more than 2,000 people, including 600 students.
Elly Margaret Tanaka is a biochemist and senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. Tanaka studies the molecular cell biology of limb and spinal cord regeneration as well as the evolution of regeneration.
Hartmut Beug (1945–2011) was a German cancer biologist who studied how groups of oncogenes interact to lead to the development and spread of cancer. Shortly before his death, a foundation was set up in his and his wife’s name to support collaboration among young scientists and their studies in the field of metastasis.
Tim Clausen is a structural biologist and a senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.
Alexander Stark is a biochemist and computational biologist working on the regulation of gene expression in development. He is a senior scientist at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter and adjunct professor of the Medical University of Vienna.
Jan O. Korbel is a German scientist working in the fields of Human Genetics, Genomics and Computational Biology. He is a tenured principal investigator and Head of Data Science at the European Molecular Biology Laboratory Heidelberg, Germany, senior scientist in the Genome Biology Unit, is leading a bridging research division at the German Cancer Research Center (DKFZ), and is an honorary professor ("Honorarprofessor") at Heidelberg University. A particular focus of the Korbel group is on investigating a particular form of mutation, genomic structural variation, which includes deletions, inversions and more complex chromosomal rearrangements such as chromothripsis events that can occur in healthy individuals and in context of disease. His group's principal research objective is to understand genomic structural variations as a basis of phenotypic variation and cancer development.
Daniel Wolfram Gerlich is a cell biologist. Since 2012 he has been a Senior Group Leader at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Dirk Schübeler is a German researcher, Director of the Friedrich Miescher Institute for Biomedical Research (FMI) and professor at the University of Basel. He is an expert in gene regulation.
Tomo Tanaka FRSE, born in Japan in 1962, is a professor and research scientist based in the Cell and Molecular Biology unit of School of Life Sciences at the University of Dundee, as well as being a Wellcome Trust Principal Research Fellow.
Tim J. Yen is an American molecular biologist and cancer biologist. Yen is currently director of the Biological Imaging Facility at Fox Chase Cancer Center in Philadelphia, Pennsylvania. Yen is known for pioneering work in the field of mitosis.
Juri Rappsilber is a German chemist in the area of mass spectrometry and proteomics.
Andrea Pauli is a developmental biologist and biochemist studying how the egg transitions into an embryo, and more specifically the molecular mechanisms underlying vertebrate fertilisations, egg dormancy, and subsequent egg activation. Her lab uses zebrafish as the main model organism. Andrea Pauli is a group leader at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter in Austria.